These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 37118924)

  • 21. LGBTQ Utilization of a Statewide Tobacco Quitline: Engagement and Quitting Behavior, 2010-2022.
    Anderson CM; Tedeschi GJ; Cummins SE; Lienemann BA; Zhuang YL; Gordon B; Hernández S; Zhu SH
    Nicotine Tob Res; 2024 Jan; 26(1):54-62. PubMed ID: 37632451
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Trends in Sales of Flavored and Menthol Tobacco Products in the United States During 2011-2015.
    Kuiper NM; Gammon D; Loomis B; Falvey K; Wang TW; King BA; Rogers T
    Nicotine Tob Res; 2018 May; 20(6):698-706. PubMed ID: 28575408
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The actual and anticipated effects of a menthol cigarette ban: a scoping review.
    Cadham CJ; Sanchez-Romero LM; Fleischer NL; Mistry R; Hirschtick JL; Meza R; Levy DT
    BMC Public Health; 2020 Jul; 20(1):1055. PubMed ID: 32641026
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Re-engagement of Low-Income Smokers in Quitline Services: Effects of Incentives and Method of Contact.
    Cummins SE; Kirby CA; Wong S; Anderson CM; Zhu SH
    Nicotine Tob Res; 2023 Mar; 25(4):796-802. PubMed ID: 36271898
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Electronic nicotine delivery system (ENDS) use during smoking cessation: a qualitative study of 40 Oklahoma quitline callers.
    Vickerman KA; Beebe LA; Schauer GL; Magnusson B; King BA
    BMJ Open; 2017 Apr; 7(4):e013079. PubMed ID: 28365587
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Effects of Offering Nicotine Patches, Incentives, or Both on Quitline Demand.
    Anderson CM; Kirby CA; Tong EK; Kohatsu ND; Zhu SH
    Am J Prev Med; 2018 Dec; 55(6 Suppl 2):S170-S177. PubMed ID: 30454671
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Flavored Tobacco Product Use and Its Association With Indicators of Tobacco Dependence Among US Adults, 2014-2015.
    Odani S; Armour B; Agaku IT
    Nicotine Tob Res; 2020 May; 22(6):1004-1015. PubMed ID: 31180498
    [TBL] [Abstract][Full Text] [Related]  

  • 28. A Comprehensive Qualitative Review of Studies Evaluating the Impact of Local US Laws Restricting the Sale of Flavored and Menthol Tobacco Products.
    Rogers T; Brown EM; Siegel-Reamer L; Rahman B; Feld AL; Patel M; Vallone D; Schillo BA
    Nicotine Tob Res; 2022 Mar; 24(4):433-443. PubMed ID: 34525207
    [TBL] [Abstract][Full Text] [Related]  

  • 29. A randomized controlled trial of directive and nondirective smoking cessation coaching through an employee quitline.
    Sumner W; Walker MS; Highstein GR; Fischer I; Yan Y; McQueen A; Fisher EB
    BMC Public Health; 2016 Jul; 16():550. PubMed ID: 27400966
    [TBL] [Abstract][Full Text] [Related]  

  • 30. How Smokers of Menthol Cigarettes and Flavored Cigars Might Respond to FDA's Proposed Bans.
    Yang Y; Lindblom EN; Ward KD; Salloum RG
    Nicotine Tob Res; 2022 Oct; 24(10):1645-1653. PubMed ID: 35353183
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Finished with Menthol: An Evidence-Based Policy Option That Will Save Lives.
    Lester JM; Gagosian SY
    J Law Med Ethics; 2017 Mar; 45(1_suppl):41-44. PubMed ID: 28661301
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Associations Between E-cigarette Use and E-cigarette Flavors With Cigarette Smoking Quit Attempts and Quit Success: Evidence From a U.S. Large, Nationally Representative 2018-2019 Survey.
    Mok Y; Jeon J; Levy DT; Meza R
    Nicotine Tob Res; 2023 Feb; 25(3):541-552. PubMed ID: 36250607
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [More] evidence to support oral health promotion services targeted to smokers calling tobacco quitlines in the United States.
    McClure JB; Riggs K; St John J; Catz SL
    BMC Public Health; 2013 Apr; 13():336. PubMed ID: 23577873
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Daily Cannabis Use Is a Barrier to Tobacco Cessation Among Tobacco Quitline Callers at 7-Month Follow-up.
    Goodwin RD; Shevorykin A; Carl E; Budney AJ; Rivard C; Wu M; McClure EA; Hyland A; Sheffer CE
    Nicotine Tob Res; 2022 Oct; 24(10):1684-1688. PubMed ID: 35417562
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Predictors of Tobacco Cessation Among American Indian/Alaska Native Adults Enrolled in a State Quitline.
    Yuan NP; Schultz JL; Nair US; Bell ML
    Subst Use Misuse; 2020; 55(3):452-459. PubMed ID: 31694464
    [No Abstract]   [Full Text] [Related]  

  • 36. Economic Impact of Financial Incentives and Mailing Nicotine Patches to Help Medicaid Smokers Quit Smoking: A Cost-Benefit Analysis.
    Sung HY; Penko J; Cummins SE; Max W; Zhu SH; Bibbins-Domingo K; Kohatsu ND
    Am J Prev Med; 2018 Dec; 55(6 Suppl 2):S148-S158. PubMed ID: 30454669
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Cessation Outcomes Among Quitline Callers in Three States During a National Tobacco Education Campaign.
    Vickerman KA; Zhang L; Malarcher A; Mowery P; Nash C
    Prev Chronic Dis; 2015 Jul; 12():E110. PubMed ID: 26182145
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Race/Ethnic Variations in Quitline Use Among US Adult Tobacco Users in 45 States, 2011-2013.
    Marshall LL; Zhang L; Malarcher AM; Mann NH; King BA; Alexander RL
    Nicotine Tob Res; 2017 Nov; 19(12):1473-1481. PubMed ID: 29121347
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Trends in Nicotine Strength in Electronic Cigarettes Sold in the United States by Flavor, Product Type, and Manufacturer, 2017-2022.
    Wang X; Ghimire R; Shrestha SS; Borowiecki M; Emery S; Trivers KF
    Nicotine Tob Res; 2023 Jun; 25(7):1355-1360. PubMed ID: 36929029
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Longitudinal associations between flavored tobacco use and tobacco product cessation in a national sample of adults.
    Steeger CM; Harlow AF; Barrington-Trimis JL; Simon P; Hill KG; Leventhal AM
    Prev Med; 2022 Aug; 161():107143. PubMed ID: 35803351
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.